San Mateo, CA, United States of America

Darren J McMurtrie

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Gilead Sciences, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Darren J McMurtrie. Retrieved from https://idiyas.com/inventor/darren-j-mcmurtrie-cn4drttm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Darren J McMurtrie

Introduction

Darren J McMurtrie is a notable inventor based in San Mateo, CA. He has made significant contributions to the field of antiviral compounds. His work focuses on developing innovative solutions to combat viral infections.

Latest Patents

Darren holds a patent for antiviral compounds. This invention relates to phosphorus substituted anti-viral inhibitory compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds. Additionally, it encompasses processes and intermediates useful for preparing these compounds. He has 1 patent to his name.

Career Highlights

Darren is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. His role involves research and development aimed at creating effective antiviral therapies. His expertise and dedication have contributed to advancements in the field.

Collaborations

Darren has worked alongside talented colleagues such as Kleem Chaudhary and Melissa Fleury. Their collaborative efforts have fostered a productive environment for innovation and research.

Conclusion

Darren J McMurtrie's work in antiviral compounds exemplifies the impact of innovative thinking in the medical field. His contributions continue to pave the way for new therapeutic methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…